However, ANKRD36 gene mutations (c.1183_1184 delGC and c.1187_1188 dupTT) were confirmed by Sanger sequencing in BC- CML patients (Figure 1), demonstrating the association between ANKRD36 variants and CML progression. Here, ANKRD36 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.